Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,066,416
-$30,008,556 QoQ
Shares Held
6,652,349
-27.7% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#17
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (42.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
6,652,349 | $62,066,416 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
567,585 | $19,229,779 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
60,224 | $10,150,152 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
17,340 | $9,395,332 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
184,209 | $8,707,559 | |
| 6 | VTRS |
Viatris Inc
|
472,511 | $7,503,474 | |
| 7 | ZTS |
Zoetis Inc.
|
96,209 | $6,913,578 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
268,328 | $4,301,297 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,066,416 | 6,652,349 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $92,074,972 | 9,198,299 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $101,139,843 | 10,003,941 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $16,938,122 | 1,888,308 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $20,535,243 | 1,980,255 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $19,731,568 | 1,917,548 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $14,571,319 | 1,527,392 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $15,592,454 | 1,473,767 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $5,019,576 | 607,697 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $4,657,596 | 548,598 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $4,497,645 | 546,494 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $3,999,424 | 480,123 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,819,048 | 336,402 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $2,035,691 | 250,085 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,926,592 | 240,824 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $1,277,541 | 209,777 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||